English
Select your language
Official EU languages:
Access to European Union law
EUR-Lex
Access to European Union law
This document is an excerpt from the EUR-Lex website
Use quotation marks to search for an "exact phrase". Append an asterisk (*) to a search term to find variations of it (transp*, 32019R*). Use a question mark (?) instead of a single character in your search term to find variations of it (ca?e finds case, cane, care).
Need more search options? Use the
Advanced search
C-175/18 P
Case C-175/18 P
C-175/18 P
Court of Justice
Status: In progress
Case on which the appeal is based: 62015TJ0718
C-175/18 P
Court of Justice
Status: In progress
Case on which the appeal is based: 62015TJ0718
/
DECISION
- Title
- Judgment of the Court (Fourth Chamber) of 22 January 2020. PTC Therapeutics International Ltd v European Medicines Agency. Appeal — Access to documents of EU institutions, bodies, offices or agencies — Regulation (EC) No 1049/2001 — First indent of Article 4(2) — Exception relating to the protection of commercial interests — Article 4(3) — Protection of the decision-making process — Documents submitted to the European Medicines Agency in the context of a marketing authorisation application for a medicinal product for human use — Decision to grant a third party access to the documents — General presumption of confidentiality — No obligation for an EU institution, body, office or agency to apply a general presumption of confidentiality. Case C-175/18 P.
- ECLI identifier
- ECLI:EU:C:2020:23
- Defendant
- European Medicines Agency
- Judge-Rapporteur
- Vilaras
- Type of procedure
- Action for annulment,Appeal - unfounded
- Complementary documents:
22/01/2020
PROCEEDINGS
- Title
- Opinion of Advocate General Hogan delivered on 11 September 2019. PTC Therapeutics International Ltd v European Medicines Agency. Appeal — Access to documents of EU institutions, bodies, offices or agencies — Regulation (EC) No 1049/2001 — First indent of Article 4(2) — Exception relating to the protection of commercial interests — Article 4(3) — Protection of the decision-making process — Documents submitted to the European Medicines Agency in the context of a marketing authorisation application for a medicinal product for human use — Decision to grant a third party access to the documents — General presumption of confidentiality — No obligation for an EU institution, body, office or agency to apply a general presumption of confidentiality. Case C-175/18 P.
- ECLI identifier
- ECLI:EU:C:2019:709
- Advocate General
- Hogan
11/09/2019